The changes in BDNF, GDNF and IGF-II in both groups may be related to several variables including the intensity and duration of the intervention, timing of measurement, genetic polymorphism and cognitive impairment, which may be clarified in future studies. The gene discussed is IGF2; the disease is Cognitive impairment.